resveratrol has been researched along with Nerve Degeneration in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (25.93) | 29.6817 |
2010's | 20 (74.07) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Estakhri, R; Hajipour, B; Saleh, BM; Zakaria, MMH | 1 |
Langmann, T; Rashid, K; Wiedemann, J | 1 |
Chomentowski, A; Drygalski, K; Fereniec, E; Kiełczewska, A; Koryciński, K; Modzelewska, B; Odrzygóźdź, C | 1 |
Baek, SH; Chung, HJ; Hong, ST; Islam, MS; Jin, YY; Kim, HJ | 1 |
Chen, JK; Chen, KH; Jing, YH; Kuo, PC; Pao, CC | 1 |
Akgul, EO; Cayci, T; Gulcan Kurt, Y | 1 |
Carlson, NG; Martinez, NE; Rose, JW; Sato, F; Shahid, M; Tsunoda, I | 1 |
Chen, J; Cui, Z; Evans, LP; Hatton, CJ; Hurst, CG; Ju, M; Juan, AM; Michan, S; Pei, DT; Sinclair, DA; Smith, LE | 1 |
Hattiangady, B; Kodali, M; Mishra, V; Rao, X; Shetty, AK; Shetty, GA; Shuai, B | 1 |
Ahmed, T; Braidy, N; Javed, S; Nabavi, SF; Nabavi, SM; Šamec, D; Tariq, A; Tejada, S | 1 |
Ak, H; Alaca, I; Alp, HH; Atalay, T; Colcimen, N; Gulsen, I; Ragbetli, MC; Sosuncu, E | 1 |
Davies, P; Dreses-Werringloer, U; Marambaud, P; Vingtdeux, V; Zhao, H | 1 |
Tang, BL | 1 |
Ahmad, A; Hoda, MN; Ishrat, T; Islam, F; Javed, H; Khan, A; Khan, MB; Khan, MM; Khuwaja, G; Raza, SS; Vaibhav, K | 1 |
Ali, SF; Beaudoin, MA; Binienda, ZK; Gough, B; Virmani, A | 1 |
Gao, HM; Hong, JS; Shi, JS; Wilson, B; Zhang, F; Zhou, H | 1 |
Bennett, JL; Gordon, LK | 1 |
Dutt, M; Elliott, P; Fitzgerald, DC; Rostami, A; Shindler, KS; Ventura, E | 1 |
Choi, DK; Koppula, S; Suk, K | 1 |
Chopra, K; Tiwari, V | 1 |
Bagatini, PB; Bernardino, GC; Coelho, GP; de Oliveira, RM; Paim, MF; Rodrigues, MF; Saur, L; Schirmer, H; Silva, DV; Souto, AA; Vianna, MR; Xavier, LL | 1 |
Anekonda, TS | 1 |
Chen, D; Guarente, L | 1 |
Baykara, B; Erbil, G; Sönmez, A; Sönmez, U; Tekmen, I | 1 |
Armour, SM; Baur, JA; Delalle, I; Dobbin, MM; Fischer, A; Kim, D; Nguyen, MD; Puigserver, P; Rodgers, JT; Sananbenesi, F; Sinclair, DA; Sui, G; Tsai, LH | 1 |
Aebischer, P; Kato, AC | 1 |
Kimelberg, HK; Lei, T; Schools, GP; Wang, W; Zhang, H; Zhou, M | 1 |
6 review(s) available for resveratrol and Nerve Degeneration
Article | Year |
---|---|
Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Caloric Restriction; Clinical Trials as Topic; Glycation End Products, Advanced; Humans; Nerve Degeneration; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Sirtuins | 2018 |
Resveratrol and Alzheimer's Disease: Mechanistic Insights.
Topics: Alzheimer Disease; Animals; Autophagy; Humans; Mitochondria; Nerve Degeneration; Oxidative Stress; Resveratrol; Stilbenes | 2017 |
Therapeutic potential of resveratrol in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Dementia; Flavonoids; Humans; Nerve Degeneration; Phenols; Polyphenols; Resveratrol; Stilbenes; Wine | 2008 |
Inhibitors of microglial neurotoxicity: focus on natural products.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzyl Alcohols; Biological Products; Biphenyl Compounds; Catechin; Catechols; Curcumin; Encephalitis; Fatty Alcohols; Ginsenosides; Glucosides; Microglia; Molecular Structure; Nerve Degeneration; Neuroprotective Agents; Phenyl Ethers; Plant Extracts; Resveratrol; Stilbenes | 2011 |
Resveratrol--a boon for treating Alzheimer's disease?
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Caloric Restriction; Humans; Nerve Degeneration; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2006 |
SIR2: a potential target for calorie restriction mimetics.
Topics: Aging; Animals; Caenorhabditis elegans; Caloric Restriction; Enzyme Inhibitors; Humans; Longevity; Metabolic Syndrome; Models, Biological; Nerve Degeneration; Resveratrol; Saccharomyces cerevisiae; Sirtuins; Stilbenes | 2007 |
21 other study(ies) available for resveratrol and Nerve Degeneration
Article | Year |
---|---|
Anti-oxidative effect of resveratrol on aluminum induced toxicity in rat cerebral tissue.
Topics: Aluminum Compounds; Animals; Antioxidants; Brain; Lipid Peroxidation; Male; Nerve Degeneration; Neuroglia; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2017 |
Resveratrol induces dynamic changes to the microglia transcriptome, inhibiting inflammatory pathways and protecting against microglia-mediated photoreceptor apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cell Movement; Lipopolysaccharides; Mice; Microglia; Models, Neurological; Nerve Degeneration; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; Phagocytosis; Photoreceptor Cells, Vertebrate; Pseudopodia; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Transcriptome | 2018 |
Effect of the Resveratrol Rice DJ526 on Longevity.
Topics: Animals; Drosophila melanogaster; Eye; Female; Food, Fortified; Locomotion; Longevity; Male; Nerve Degeneration; Nervous System; Nutritive Value; Oryza; Resveratrol; Time Factors; Weight Gain | 2019 |
Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol.
Topics: Animals; Antioxidants; Astrocytes; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Hippocampus; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2013 |
Two-dimensional evaluations for mitochondrial number are not reliable. Re: 'neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol' by Jing et al.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Male; Nerve Degeneration; Resveratrol; Stilbenes | 2013 |
Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.
Topics: Animals; Autoimmunity; Axons; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nerve Degeneration; Neuroprotective Agents; Resveratrol; Stilbenes; Theilovirus; Virulence | 2013 |
Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy.
Topics: Animals; Crosses, Genetic; Disease Models, Animal; Endothelial Cells; Gene Expression; Heterocyclic Compounds, 4 or More Rings; Humans; Integrases; Macrophages; Mice; Neovascularization, Pathologic; Nerve Degeneration; Nestin; Neurons; Oxygen; Receptor, TIE-2; Resveratrol; Retina; Retinal Degeneration; Sirtuin 1; Stilbenes | 2014 |
Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation.
Topics: Animals; Behavior, Animal; Cell Adhesion Molecules, Neuronal; Cell Death; Cognition; Extracellular Matrix Proteins; GABAergic Neurons; Gene Expression Regulation; Hippocampus; Inflammation; Interneurons; Longevity; Male; Microglia; Nerve Degeneration; Nerve Tissue Proteins; Neurogenesis; Neuropeptide Y; Oxidative Stress; Parvalbumins; Rats, Inbred F344; Reelin Protein; Resveratrol; Seizures; Serine Endopeptidases; Somatostatin; Status Epilepticus; Stilbenes; Tumor Necrosis Factor-alpha | 2015 |
Resveratrol Treatment Prevents Hippocampal Neurodegeneration in a Rodent Model of Traumatic Brain Injury.
Topics: Animals; Antioxidants; Brain Injuries, Traumatic; DNA Damage; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Rats; Resveratrol; Stilbenes; Superoxide Dismutase | 2017 |
Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
Topics: AMP-Activated Protein Kinases; Animals; Brain; Cell Death; Models, Neurological; NAD; Nerve Degeneration; Neurons; Neuroprotective Agents; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2010 |
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Disease Models, Animal; Dopamine; Enzymes; Free Radicals; Glutathione; Lipid Peroxidation; Male; Nerve Degeneration; Neurotoxins; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phospholipases A2; Rats; Rats, Wistar; Resveratrol; Stilbenes; Substantia Nigra; Thiobarbituric Acid Reactive Substances; Treatment Outcome | 2010 |
Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.
Topics: Acetylcarnitine; Animals; Antioxidants; Axons; Environmental Pollutants; Male; Nerve Degeneration; Neural Conduction; Neuroprotective Agents; Nitro Compounds; Peripheral Nervous System Diseases; Propionates; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2010 |
Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Topics: Animals; Anti-Inflammatory Agents; Dopamine; Embryo, Mammalian; Female; Flavonoids; Lipopolysaccharides; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Mitogen-Activated Protein Kinases; NADPH Oxidases; Nerve Degeneration; Neuroglia; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinson Disease; Phenols; Polyphenols; Pregnancy; Rats; Rats, Inbred F344; Reactive Oxygen Species; Resveratrol; Stilbenes; Substantia Nigra | 2010 |
Preserving and restoring optic nerve function.
Topics: Animals; Cell Survival; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Multiple Sclerosis; Nerve Degeneration; Nerve Regeneration; Optic Nerve; Optic Nerve Diseases; Resveratrol; Retinal Ganglion Cells; Stilbenes | 2010 |
Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Multiple Sclerosis; Nerve Degeneration; Resveratrol; Stilbenes | 2010 |
Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Antioxidants; Brain Damage, Chronic; Caspase 3; Cell Death; Central Nervous System Depressants; Cognition Disorders; Ethanol; Inflammation; Lipid Peroxidation; Male; Maze Learning; Memory; Nerve Degeneration; Neuroprotective Agents; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Superoxide Dismutase | 2011 |
The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Disease Models, Animal; Dopamine; Drosophila melanogaster; Nerve Degeneration; Paraquat; Parkinsonian Disorders; Resveratrol; Stilbenes; Substantia Nigra | 2011 |
Neuroprotective effects of resveratrol against traumatic brain injury in immature rats.
Topics: Animals; Animals, Newborn; Antioxidants; Anxiety; Brain Injuries; Cell Death; Cognition Disorders; Hippocampus; Injections, Intraperitoneal; Memory; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Treatment Outcome | 2007 |
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.
Topics: Acetylation; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Cyclin-Dependent Kinase 5; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Mutation; Nerve Degeneration; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; Tumor Suppressor Protein p53 | 2007 |
Playng defense against Lou Gehrig's disease.
Topics: Amyotrophic Lateral Sclerosis; Animals; Axons; Brain; Cell Death; Exercise; Humans; Male; Motor Neurons; Nerve Degeneration; Nerve Growth Factors; Resveratrol; RNA Interference; Spinal Cord; Stem Cell Transplantation; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1 | 2007 |
Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation.
Topics: Action Potentials; Animals; Antioxidants; Carbocyanines; Cell Death; Hippocampus; Hypoxia-Ischemia, Brain; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Nerve Degeneration; Organ Culture Techniques; Potassium Channel Blockers; Pyramidal Cells; Rats; Resveratrol; Stilbenes; Time Factors | 2008 |